Efficacy of Manuel Pressure and Local Cold Spray in Reducing Injection Pain in Pregnant Women

Launched by GULSUM COSKUN · Jan 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how manual pressure and a cold spray can help reduce pain during an injection of a medication called Anti-D immunoglobulin in pregnant women. The goal is to see if these techniques can make the injection experience less painful and more comfortable for women who are 20 weeks pregnant or more.

To be part of this study, participants need to be women aged 18 to 45 who can understand Turkish and are not experiencing any complications from previous injections. They should not have had any injections in the week before the study and should not be taking pain relief medications. If they join, they can expect to receive either the manual pressure technique, the cold spray, or standard care during their injection, and their experiences will be carefully monitored to assess pain levels and overall satisfaction. This trial is currently active but not recruiting new participants.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Ability to understand, speak, read and understand Turkish
• • Volunteering to participate in the study
• • Being pregnant (gestational week 20 and above)
• • Being between the ages of 18-45
• • Has not had an IM injection in the last week
• • There are no complications related to IM injections such as pain, abscess, infection, tissue necrosis, hematoma at the IM injection site.
• • Not taking any analgesics before the procedure
• • No chronic disease
• • Those who do not have visual or cognitive impairments that prevent them from marking measurement tools
• Exclusion Criteria:
• • Not volunteering to participate in the study
• • Having chronic pain disorders